SoftBank Revives $10B OpenAI Margin Loan with a Corporate Guarantee — Here's the Full Timeline

May 6–8, 2026 — After "hesitation from some creditors" over pricing and valuation risk, SoftBank cut the target by 40% to $6 billion . The downsizing was the clearest signal that even OpenAI's $852 billion primary round valuation had not closed the gap between sticker price and what banks would lend against .

May 7, 2026 — Simultaneously, SoftBank secured a separate $40 billion unsecured bridge loan arranged by JPMorgan Chase, Goldman Sachs, Mizuho, SMBC, and MUFG, maturing in March 2027, to fund its OpenAI follow-on investment .

June 10, 2026 — Bloomberg reported that even the $6 billion margin loan talks had stalled. SoftBank's stock dropped nearly 10% on the news . The company began considering various alternative fundraising options .

Late June / July 1, 2026 — Reuters exclusively reported that SoftBank had revived talks for the full $10 billion, now offering a corporate guarantee that would kick in if the OpenAI collateral proves insufficient upon any margin call or default . This full-recourse backstop from SoftBank Group itself is designed to bridge the valuation uncertainty gap that had blocked the deal.

The New Structure: A Corporate Guarantee

The key change is that SoftBank is now offering its own corporate guarantee as a sweetener. If the OpenAI collateral is insufficient during a margin call or default, SoftBank Group itself would cover the shortfall. This converts the loan from a limited-recourse structure (secured only by OpenAI shares) to one with a full-recourse backstop from the parent company .

Expected Lending Consortium

Three banks are confirmed to be in talks for the revived loan:

• Goldman Sachs
• JPMorgan Chase
• Mizuho Financial Group

These three were already involved in earlier discussions and are again at the table for the current structure .

Broader Context: SoftBank's $64.6 Billion OpenAI Bet

The margin loan saga cannot be understood in isolation. It is a piece of a much larger financing puzzle:

• On February 27, 2026, SoftBank entered a definitive agreement to invest an additional $30 billion into OpenAI via Vision Fund 2 .
• This brings SoftBank's total cumulative investment to approximately $64.6 billion, representing roughly a 13% ownership stake in OpenAI .
• The $30 billion follow-on is being funded in tranches. By October 2026, the full amount is expected to be deployed .
• SoftBank's $34.6 billion already deployed as of March 31, 2026, was marked at a fair value of $79.6 billion on its books, generating a massive paper gain of roughly $45 billion for the fiscal year .
• The separate $40 billion unsecured bridge loan is the primary near-term financing vehicle for the OpenAI investment, while the margin loan is a supplementary source . The bridge loan matures in March 2027, which creates a near-term refinancing need .

Why Banks Are Increasingly Cautious on Private-Company Loans

The softBank saga reflects a broader trend: growing reluctance among banks to accept illiquid private-company shares as collateral. The reasons include:

Valuation opacity — OpenAI has no public trading price, and its valuation jumps dramatically between funding rounds. Banks struggle to set defensible loan-to-value ratios .

Lack of a margin-call mechanism — If the collateral is not publicly traded, a lender cannot quickly liquidate shares in a stress scenario. This is fundamentally different from margin loans against public stocks like Arm or Nvidia .

Concentration risk — SoftBank is effectively asking lenders to take concentrated exposure to a single unlisted AI company that is already the core of SoftBank's own balance sheet .

IPO uncertainty — While OpenAI filed confidentially for a U.S. IPO in May 2026, no date or valuation range has been set, leaving lenders without a clear exit timeline .

The contrast with SoftBank's earlier margin loan against Arm stock (a public company), which closed successfully in 2025, underscores the difference: lenders are willing to lend against publicly traded shares but remain skeptical of private-company collateral .